Foseco India Ltd vs Link Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Foseco India Ltd is ₹ 5245 as of 18 Mar 15:30 . The p/e ratio of Foseco India Ltd changed from 27.8 to 0 over 9 quarters. This represents a CAGR of -100.00% The p/e ratio of Link Pharma Chem Ltd changed from 9.7 to 0 over 5 quarters. This represents a CAGR of -100.00% The market cap of Foseco India Ltd changed from ₹ 908.63 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The market cap of Link Pharma Chem Ltd changed from ₹ 10.5 crore to ₹ 15.01 crore over 5 quarters. This represents a CAGR of 33.09% The Revenue of Foseco India Ltd is ₹ 154.3 crore as of Dec '25 .The Revenue of Link Pharma Chem Ltd is ₹ 0 crore as of Dec '25 . The EBITDA of Foseco India Ltd is ₹ 26.33 crore as of Dec '25 .The EBITDA of Link Pharma Chem Ltd is ₹ 0 crore as of Dec '25 . The Net Profit of Foseco India Ltd is ₹ 16.49 crore as of Dec '25 .The Net Profit of Link Pharma Chem Ltd is ₹ 0 crore as of Dec '25 . The dividend payout of Foseco India Ltd changed from 48.9 % to 0 % over 9 quarters. This represents a CAGR of -100.00% The dividend payout of Link Pharma Chem Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% .

About Foseco India Ltd

Foseco India Limited is a global leader in providing foundry consumables and solutions, emphasising consistency and productivity in the foundry process.
By leveraging advanced solutions and computer simulation techniques, Company empowers foundries to reduce casting defects and enhance product quality.
Foseco's products are designed to minimise labour-intensive fettling and machining, optimise metal usage, and automate critical processes such as moulding and casting.
Founded in 1958, Foseco India Limited has over six decades of experience and has earned a reputation for sustainability, safety, and social responsibility alongside its technical and engineering expertise. Foseco India Limited, incorporated on March 22, 1958 is a world leader in the supply of foundry consumables and solutions.

About Link Pharma Chem Ltd

Link Pharma Chem Ltd (LPCL) is a mid-size leading chemical manufacturing company, incorporated in the year 1986.
The Company operate in the small-scale sector to manufacture 300 tpa of thionil chloride(TC).
The Company increased its capacity to 1500 tpa in 1989 to meet the growing demand.
It undertook a further expansion in 1993 with assistance from SIDBI to increase capacity to 2100 tpa, which was completed in 1994. The Company is engaged in manufacturing and exporting multi range intermediates for pharmaceutical, agro industries and specialty chemicals.
It is engaged in custom synthesis / contract manufacturing for multistage synthesis for small, medium, large companies as well.

FAQs for the comparison of Foseco India Ltd and Link Pharma Chem Ltd

Which company has a larger market capitalization, Foseco India Ltd or Link Pharma Chem Ltd?

Market cap of Foseco India Ltd is 3,953 Cr while Market cap of Link Pharma Chem Ltd is 10 Cr

What are the key factors driving the stock performance of Foseco India Ltd and Link Pharma Chem Ltd?

The stock performance of Foseco India Ltd and Link Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Foseco India Ltd and Link Pharma Chem Ltd?

As of March 18, 2026, the Foseco India Ltd stock price is INR ₹5245.45. On the other hand, Link Pharma Chem Ltd stock price is INR ₹24.49.

How do dividend payouts of Foseco India Ltd and Link Pharma Chem Ltd compare?

To compare the dividend payouts of Foseco India Ltd and Link Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.